UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Canine thyroid carcinoma prognosis following the utilisation of computed tomography assisted staging

Veterinary record, 2021-07, Vol.189 (1), p.no-no

2021

Link zum Volltext

Verfügbarkeit prüfen

FGFR a promising druggable target in cancer: molecular biology and new drugs

Critical reviews in oncology/hematology, 2017-05, Vol.113, p.256-267

2017

Link zum Volltext

Verfügbarkeit prüfen

cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance

Cancers, 2015-03, Vol.7 (2), p.556-573

2015

Link zum Volltext

Verfügbarkeit prüfen

Resistance Mechanisms to AZD9291 and Rociletinib-Letter

Clinical cancer research, 2017-07, Vol.23 (14), p.3966-3966

2017

Link zum Volltext

Verfügbarkeit prüfen

The Circular RNA Landscape of Non-Small Cell Lung Cancer Cells

Cancers, 2020-04, Vol.12 (5), p.1091

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cells

American journal of cancer research, 2017-01, Vol.7 (4), p.816-830

2017

Link zum Volltext

Verfügbarkeit prüfen

Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer

World journal of clinical oncology, 2016-12, Vol.7 (6), p.425-432

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical and clinicopathological features and outcomes of cats with suspected dietary induced pancytopenia

Journal of veterinary internal medicine, 2023-01, Vol.37 (1), p.126-132

2023

Link zum Volltext

Verfügbarkeit prüfen

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

OncoTargets and therapy, 2016-01, Vol.9, p.6065-6074

2016

Link zum Volltext

Verfügbarkeit prüfen

Meloxicam in Combination with Mitoxantrone or Vinblastine as First-Line Treatment for Non-Resectable Urothelial Cell Carcinoma in Dogs

Veterinary sciences, 2023-08, Vol.10 (8), p.529

2023

Link zum Volltext

Verfügbarkeit prüfen

Onartuzumab in lung cancer: the fall of Icarus?

Expert review of anticancer therapy, 2015-05, Vol.15 (5), p.487-489

2015

Link zum Volltext

Verfügbarkeit prüfen

APR-246 (PRIMA-1MET ) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines

Cancer letters, 2016-06, Vol.375 (2), p.313-322

2016

Link zum Volltext

Verfügbarkeit prüfen

cMET Exon 14 Skipping: From the Structure to the Clinic

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1423-1432

2016

Link zum Volltext

Verfügbarkeit prüfen

Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line

Biochemical pharmacology, 2019-08, Vol.166, p.128-138

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1074: Combining forces: Synergy of erlotinib and crizotinib in a wild-type squamous non-small cell lung cancer cell line

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1074-1074

2017

Link zum Volltext

Verfügbarkeit prüfen

The PI3K-Akt signaling leads to synergy of erlotinib and crizotinib in wild-type NSCLC

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20043-e20043

2017

Link zum Volltext

Verfügbarkeit prüfen

Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Journal of visualized experiments, 2016-05 (111)

2016

Link zum Volltext

Verfügbarkeit prüfen

Sinonasal mycosis following transfrontal craniotomy in three dogs

Journal of the American Veterinary Medical Association, 2022-03, Vol.260 (6), p.643

2022

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Chemotherapy: A Glimmer of Hope?

Journal of clinical oncology, 2017-02, Vol.35 (6), p.692-693

2017

Link zum Volltext

Verfügbarkeit prüfen

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function

Journal of cellular physiology, 2020-11, Vol.235 (11), p.8085-8097

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2593: Combination therapy with EGFR-TKI and cMET-TKIs in non-small cell lung cancer: the golden duo

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2593-2593

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2242: cMET in non-small cell lung cancer: pieces of the puzzle

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2242-2242

2016

Link zum Volltext

Verfügbarkeit prüfen

P2.06: Exosomal miRNA Analysis in Non-Small Cell Lung Cancer: New Liquid Biomarker?

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.S219-S220

2016

Link zum Volltext

Verfügbarkeit prüfen

P2.09: cMET in NSCLC: Expression, Amplification and Mutations

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.S221-S222

2016

Link zum Volltext

Verfügbarkeit prüfen

P2.09: cMET in NSCLC: Expression, Amplification and Mutations: Track: Biology and Pathogenesis

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.S221-S222

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(69)
Webseiten
(1)

Sprache

Englisch
(70)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(52)
Humans
(30)
Palliative Care
(18)
Nursing Homes
(17)
Male
(16)
Female
(15)
Oncology
(15)
Aged
(14)
Health Care Sciences & Services
(11)
End-Of-Life Care
(9)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Aged, 80 And Over
(7)
Cross-Sectional Studies
(7)
Dementia
(7)
Europe
(7)
Long Term Care
(7)
Carcinoma, Non-Small-Cell Lung - Genetics
(6)
Cmet
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Canine thyroid carcinoma prognosis following the utilisation of computed tomography assisted staging

FGFR a promising druggable target in cancer: molecular biology and new drugs

cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance

Resistance Mechanisms to AZD9291 and Rociletinib-Letter

The Circular RNA Landscape of Non-Small Cell Lung Cancer Cells

Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cells

Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer

Clinical and clinicopathological features and outcomes of cats with suspected dietary induced pancytopenia

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

Meloxicam in Combination with Mitoxantrone or Vinblastine as First-Line Treatment for Non-Resectable Urothelial Cell Carcinoma in Dogs

Onartuzumab in lung cancer: the fall of Icarus?

APR-246 (PRIMA-1MET ) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines

cMET Exon 14 Skipping: From the Structure to the Clinic

Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line

Abstract 1074: Combining forces: Synergy of erlotinib and crizotinib in a wild-type squamous non-small cell lung cancer cell line

The PI3K-Akt signaling leads to synergy of erlotinib and crizotinib in wild-type NSCLC

Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Sinonasal mycosis following transfrontal craniotomy in three dogs

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Chemotherapy: A Glimmer of Hope?

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function

Abstract 2593: Combination therapy with EGFR-TKI and cMET-TKIs in non-small cell lung cancer: the golden duo

Abstract 2242: cMET in non-small cell lung cancer: pieces of the puzzle

P2.06: Exosomal miRNA Analysis in Non-Small Cell Lung Cancer: New Liquid Biomarker?

P2.09: cMET in NSCLC: Expression, Amplification and Mutations

P2.09: cMET in NSCLC: Expression, Amplification and Mutations: Track: Biology and Pathogenesis

Suchergebnisse filtern